Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire
about
Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South AfricaStavudine toxicity in adult longer-term ART patients in Blantyre, MalawiProcurement and Supply Management System for MDR-TB in Nigeria: Are the Early Warning Targets for Drug Stock Outs and Over Stock of Drugs Being Achieved?The 90 90 90 strategy to end the HIV Pandemic by 2030: Can the supply chain handle it?Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.Global HIV epidemiology: A guide for strategies in prevention and care.Medicine shortages in Fiji: A qualitative exploration of stakeholders' views.Treatment retention and care transitions during and after the scale-up of HIV care and treatment in Northern Tanzania.Multi-level factors affecting entry into and engagement in the HIV continuum of care in Iringa, TanzaniaThe Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and ZimbabweA South African public-private partnership HIV treatment model: viability and success factors.Improving HIV outcomes in resource-limited countries: the importance of quality indicators.Pharmaceutical availability across levels of care: evidence from facility surveys in Ghana, Kenya, and Uganda."Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.High level of HIV-1 drug resistance among patients with HIV-1 and HIV-1/2 dual infections in Guinea-Bissau.Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysisStock-outs of antiretroviral drugs and coping strategies used to prevent changes in treatment regimens in Kinondoni District, Tanzania: a cross-sectional study.Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.Retention in care and medication adherence: current challenges to antiretroviral therapy success.Antiretroviral drug supply challenges in the era of scaling up ART in MalawiEarly outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa.HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHODThe Impact of Inventory Management on Stock-Outs of Essential Drugs in Sub-Saharan Africa: Secondary Analysis of a Field Experiment in Zambia.Successes and Challenges of HIV Mentoring in Malawi: The Mentee Perspective.Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.HIV/AIDS related commodities supply chain management in public health facilities of Addis Ababa, Ethiopia: a cross-sectional survey.Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy.Breastfeeding: the hidden barrier in Côte d'Ivoire's quest to eliminate mother-to-child transmission of HIV.Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review.Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy.Programmatic and ethical challenges in the implementation of treatment-as-prevention in the context of HIV and drug-resistant tuberculosis co-infection in sub-Saharan Africa.Reducing stock-outs of essential tuberculosis medicines: a system dynamics modelling approach to supply chain management.Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.The HIV basic care package: where is it available and who receives it? Findings from a mixed methods evaluation in Kenya and Uganda.Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa.Improved Retention with Six Month Clinic Return Intervals for Stable HIV-Infected Patients in Zambia.Investigating the continuous synthesis of a nicotinonitrile precursor to nevirapine.Supply kits for antenatal and childbirth care: a systematic review.
P2860
Q28481468-8199D748-9D94-4A9E-9750-972B3437ECD7Q28481581-2082E1AC-6694-4EA5-9AF8-398C2630DC5AQ28548557-1FED6401-F268-4A93-A35F-756AC4A68797Q30390065-49880219-4D68-4D7D-94E4-AA174E982CD9Q33670735-80C8021A-1DC4-4EA6-89DE-AE2F6B7B728BQ33703135-9A3E8A32-E454-4E0E-B160-B2CA83F0EAE8Q33765126-8E149864-200B-4BD6-8443-DDF8F66FCF3AQ34005931-C6E1837C-AE9D-4609-9746-1D501E12CB73Q34066025-DA87D834-A73F-406A-969F-D569A0C8AC25Q34107634-140AA0B3-F424-4526-A8D4-C2B2375FDBE8Q34374299-E222A264-BB84-4A12-9AA4-939F02D65F9BQ34487057-9DEF609E-7238-4A4A-A99D-D0105A7F392AQ34681477-51B7BB9E-9929-480C-A3FC-F5B3BC364FE1Q35100096-7188E600-6F03-4BF8-87F2-D297FF4E3210Q35119753-96A0E8FD-A378-42F0-ADA7-0D2230DA9F2DQ35170089-E92F5C89-9473-427B-88B5-A3F78D5592B2Q35197266-3A99C5B5-BB10-448A-A9DA-E32F693C74D1Q35198457-E3039C8A-FB80-4F94-8990-F09D3C46919DQ35217508-C5525246-5862-43C3-9257-16E19B750E8BQ35257824-483AC104-235B-49C1-8060-48B0FBCD4583Q35357591-6310ABDC-47CF-4156-AE5A-8AD64B485BA6Q35575725-7FD481B0-A66A-4587-8C0B-DBB61493CA9BQ35917583-F8D4F809-9039-45EC-8132-38B4497C0163Q35948083-581BC4D4-6AEC-4C69-B276-9622B7D2DEA2Q36030055-C5BF3B3C-C8A6-487B-849E-7CB19F533A3BQ36063344-72483D39-48DA-4F11-9EC5-9868CA2CF877Q36414972-F6A240FE-83B7-4E38-99F2-EBE1A8ABA9DCQ36758623-4D97CD76-7BF0-44EA-919A-3D977EF39B3EQ37404322-C7CE811B-7D52-44C6-B7C3-C3F319E8378DQ37710421-EAEC941F-E56E-47D3-BE15-4CDAE1C0FD77Q37896165-040E1F8B-1AB2-4EAC-9CC3-7BE7EAD38392Q38195928-A4CF1601-3A90-4C54-AFA0-D8BEE97A462BQ38393167-76C431E8-7F1B-4759-82B2-075420126507Q38679354-A26D0871-350D-4693-86A9-96992ED14BCEQ38851140-604B9C66-079A-4BEB-A8DE-98D1FF1D3552Q38863238-6F62E10E-7702-42BB-B9F6-40A681FA66EBQ39174707-9E5AE21E-1177-4B4B-9951-562EBF8FC945Q41987081-AF923423-E8B4-4767-8FA5-F1307E47AD1EQ42010738-A4861161-C47E-4887-A543-5C6B8B2C6605Q46300834-69538D2E-8D56-4E22-8FFE-FA413C8BD43D
P2860
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@ast
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@en
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@nl
type
label
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@ast
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@en
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@nl
prefLabel
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@ast
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@en
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@nl
P2093
P2860
P50
P3181
P1433
P1476
Impact of drug stock-outs on d ...... rapy in Abidjan, Côte d'Ivoire
@en
P2093
Albert Minga
Armelle Pasquet
Ayeby Depoulosky
Eugène Messou
Sylvie Deuffic-Burban
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0013414
P407
P50
P577
2010-10-15T00:00:00Z